Cellceutix Corporation announced the informed shareholders that its Chief Medical Officer, Dr. Daniel Jorgensen, will be leaving the company, effective March 31, 2016, in order to pursue a unique opportunity in his specialized field at a privately held company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | 0.00% | 0.00% | -69.39% |
02-01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-69.39% | 794K | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- IPIX Stock
- News Innovation Pharmaceuticals Inc.
- Daniel Jorgensen Leaves Cellceutix Corporation as Chief Medical Officer, Effective March 31, 2016